
OR Royalties Inc. (NYSE:OR – Free Report) – Equities researchers at Scotiabank cut their FY2026 earnings per share (EPS) estimates for shares of OR Royalties in a report issued on Thursday, March 5th. Scotiabank analyst T. Jakusconek now anticipates that the basic materials company will post earnings of $1.20 per share for the year, down from their previous forecast of $1.39. Scotiabank has a “Sector Perform” rating and a $51.00 price objective on the stock. The consensus estimate for OR Royalties’ current full-year earnings is $0.62 per share. Scotiabank also issued estimates for OR Royalties’ FY2027 earnings at $1.31 EPS.
A number of other analysts also recently weighed in on OR. Canadian Imperial Bank of Commerce reissued an “outperform” rating on shares of OR Royalties in a report on Wednesday, February 4th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of OR Royalties in a research report on Monday, December 29th. Jefferies Financial Group reiterated a “hold” rating and issued a $38.00 target price on shares of OR Royalties in a research note on Sunday, December 7th. Zacks Research raised OR Royalties from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 4th. Finally, TD Securities restated a “hold” rating on shares of OR Royalties in a research note on Monday, February 23rd. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, OR Royalties presently has an average rating of “Moderate Buy” and a consensus target price of $38.25.
OR Royalties Trading Up 0.0%
Shares of OR stock opened at $43.06 on Monday. The firm has a market capitalization of $8.07 billion, a P/E ratio of 39.50 and a beta of 0.75. OR Royalties has a 1 year low of $17.61 and a 1 year high of $48.06. The firm’s fifty day simple moving average is $41.77 and its 200 day simple moving average is $37.34.
OR Royalties (NYSE:OR – Get Free Report) last posted its quarterly earnings data on Wednesday, February 18th. The basic materials company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.01. The company had revenue of $90.47 million during the quarter, compared to analysts’ expectations of $90.80 million. OR Royalties had a return on equity of 12.73% and a net margin of 74.30%.
Hedge Funds Weigh In On OR Royalties
Hedge funds and other institutional investors have recently made changes to their positions in the business. Forge First Asset Management Inc. acquired a new position in OR Royalties in the second quarter worth about $2,385,000. Horizon Kinetics Asset Management LLC lifted its stake in OR Royalties by 6.7% during the second quarter. Horizon Kinetics Asset Management LLC now owns 1,817,501 shares of the basic materials company’s stock worth $46,728,000 after purchasing an additional 114,464 shares during the period. CWA Asset Management Group LLC boosted its holdings in OR Royalties by 112.6% during the third quarter. CWA Asset Management Group LLC now owns 381,747 shares of the basic materials company’s stock valued at $15,300,000 after purchasing an additional 202,173 shares in the last quarter. Alps Advisors Inc. acquired a new stake in OR Royalties during the third quarter valued at approximately $2,649,000. Finally, Synergy Asset Management LLC grew its stake in shares of OR Royalties by 200.0% in the 3rd quarter. Synergy Asset Management LLC now owns 52,851 shares of the basic materials company’s stock valued at $2,118,000 after purchasing an additional 35,234 shares during the period. 68.52% of the stock is owned by institutional investors.
OR Royalties Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Tuesday, March 31st will be issued a $0.055 dividend. This represents a $0.22 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Tuesday, March 31st. OR Royalties’s payout ratio is 20.18%.
About OR Royalties
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
Recommended Stories
- Five stocks we like better than OR Royalties
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
